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Abstract
Background: Adult hematopoietic stem cells (HSCs), the ideal system for regenerative research, were isolated at
single cell levels decades ago, whereas studies on embryonic HSCs are much more difficult.
Methods: Zhou et al identified a new pre-HSC cell surface marker, CD201, by which they isolated pre-HSCs at
single cell levels for further analyses.
Results: The novel expression pattern of HSC development is revealed, including the fundamental role of mammalian
targets of rapamycin (mTOR) signaling pathway in HSCs emergence, and the repopulation potential of S/G2/M phase
pre-HSCs.
Conclusions: Deeper understandings of the cellular origin and developmental regulatory network of HSCs are
essential to develop new strategies of generating HSCs in vitro for clinical application.
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Hematopoietic stem cells (HSCs) give rise to the entire
blood cellular components. Due to the scarcity of HSCs
(only one in every 10,000 to 15,000 bone marrow cells),
only a limited number of the patients could have the
chance to benefit from HSC transplantation, which is
considered the most effective way to cure malignant
hematologic diseases and many other genetic diseases.
The supply of HSCs severely hinders broader applications
of HSC in regenerative medicine. In 2006, Yamanaka
invented the technology of reprogramming the somatic
cells into the induced pluripotent stem (iPS) cells, which
fundamentally altered the traditional theory that cell
identity is fixed once terminally differentiated [1, 2]. The
application of cell identity switches provides a potential
strategy in generating enough quantity of HSCs for clinical
application. However, to date, induction of HSCs from
pluripotent stem cells, including embryonic stem cells
and iPS cells, has been very inefficient, and thus has
not been applied in the clinic. One of the obstacles is
the elusiveness of the origin of HSCs. To generate func-
tional HSCs requires capturing the precise stem cell
state, which ensures retaining their proliferation and
self-renewal activity after engraftment. Deeper under-
standings of HSC-specific cell identity as well as their
regulatory pathways still need to be made.
During mammalian embryonic development, at least two
waves of hematopoiesis take place, primitive hematopoiesis
that generates mostly myeloid cells and erythrocytes,
and definitive hematopoiesis that produces HSCs with
long-term reconstitution and multi-lineage potential.
Definitive HSCs are believed to be derived from hemo-
genic endothelium cells (EC). The earliest HSCs can be
detected at embryonic day (E) 10.5 in aorta-gonad-meso-
nephros (AGM) region, when the number of definitive
HSCs is less than one per embryo [3]. Around E11, two
types of immature HSCs, CD45− pre-HSCs (T1 pre-
HSCs) and later CD45+ pre-HSCs (T2 pre-HSCs), were
identified to be capable of developing into long-term
repopulating definitive HSCs [4]. Then, the CD45+
HSCs start to migrate into fetal liver (FL) at E11.5,
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5 days, and then be released into circulating blood and
finally settle in the future adult bone marrow and
spleen. To specify gene expression patterns of HSC pre-
cursors and HSCs at different stages [5] is fundamental
for elucidating HSCs cell identity transitions.
Due to the small number, limited time span, and
rapid change of surface markers of HSCs during the
early stage of embryonic development, it is of great dif-
ficulty to clarify the mechanisms in gene expression
levels. Therefore, single cell tracing would be an ideal
approach, which has been used to achieve the temporal
regulatory gene expression profiling of hematopoietic dif-
ferentiation for adult HSCs [6, 7]. Recently, Zhou et al
captured the pre-HSCs at the single cell levels for the first
time, and performed the single cell RNA-seq analyses, in
which they identified new markers for pre-HSC isolation,
revealed indispensable role of activation of mammalian
targets of rapamycin (mTOR)/Rictor pathway in HSC
generation, and demonstrated unique cell-cycle status of
pre-HSCs, thus to advance the knowledge of complex
regulation of HSCs during development [8] (Fig. 1).
CD201 (also known as endothelial protein C receptor,
EPCR), combined with SLAM markers has been used to
define a rare population with HSC activity throughout life-
time [9]. Previous analyses on embryonic HSCs began from
E14.5 fetal liver when HSCs are able to be transplanted
directly without in vitro priming. Yet the specific markers
to enrich HSC precursors from early embryonic days re-
main unexplored. In combination with other T1 pre-HSC
markers (CD31+CD45−CD41lowc-Kit+CD201high), Zhou et
al isolated single T1 pre-HSC cells, which showed robust
self-renewal capability in serial transplantations. Single cell
RNA-seq analyses were performed using samples from five
different stages of HSC precursors and HSCs (E11 ECs,
E11 T1 pre-HSCs, E11 T2 pre-HSCs, E12 and E14 fetal
liver HSCs), of which the result suggests that one subpopu-
lation among T2 pre-HSCs (CD31+CD45+c-Kit+) showed
similar gene signatures to T1 pre-HSCs with high expres-
sion of CD201. Single cell transplantation confirmed the
enrichment of HSC potential cells in this CD201high T2
subpopulation. Zhou et al’s work showed that CD201 is a
potent pre-HSC enrichment marker for the first time. The
discovery of new pre-HSC maker ensures single cell acqui-
sition throughout the entire HSC development hierarchy,
and provides reliable basis for further understanding of
HSC development.
Fig. 1 New findings on precursors of HSCs. Hematopoietic stem cells (HSCs) are believed to develop from hemogenic endothelium (EC) cells. The
earliest HSCs that are capable of reconstitution potential emerge at embryonic day (E) 10.5 in aorta-gonad-mesonephros (AGM) region, then
later migrate to fetal liver, and finally settle in the future adult bone marrow and spleen. The identification of cell surface markers of different
stage HSCs facilitate for efficient enrichment of HSCs, thus to elucidate HSC development transcriptional machinery. Recently, CD201 (endothelial
protein C receptor, EPCR) was identified as a pre-hematopoietic stem cells (pre-HSCs) surface marker for the first time. By isolation and analyses of
pre-HSCs at single cell levels, unique cell-cycle features of pre-HSCs were discovered. Different from past studies that most of adult HSCs reside
in G0 phase and none of the S/G2/M phase adult HSCs could successfully reconstitute, transplantation of S/G2/M phase pre-HSCs demon-
strates most robust reconstitution capability, G0 phase pre-HSCs show moderate activity, and none of the G1 phase pre-HSCs is able to recon-
stitute. During the development of HSCs, activation of mammalian targets of rapamycin (mTOR) signaling pathway is fundamental for
HSCs emergence
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Single cell RNA-seq analyses also revealed new signal-
ing pathways controlling HSC formation, among which
mTOR signaling pathway stood out for its potential role
in regulating HSC function. Noticing overt mTORC2 ac-
tivation in T1 pre-HSCs, Zhou et al conducted function
analysis using Rictor (a main component of the MTOR2
complex) conditional knock-out murine models. They
specified that Rictor is required for HSC emergence
from endothelium but not for later HSC maintenance
and function, nor hematopoietic progenitor cells (HPCs)
generation.
Another remarkable finding is the complete differ-
ence of cell-cycle status of pre-HSCs. After birth, most
adult HSCs settle in the bone marrow, where they reside
in quiescence and mainly remain in G0 phase [10, 11].
Different from adult HSCs, in which the S/G2/M phases
HSCs were found inactive, S/G2/M phase pre-HSCs show
most vigorous proliferation and reconstitution ability, G0
phase pre-HSCs show moderate repopulation potential,
and none of them are in G1 phase. This novel observation
still needs further investigation to clarify why functional
HSCs at different stage diverse so tremendously in cell-
cycle status.
The reconstitution potential of pre-HSCs that Zhou
et al showed in their work may potentially provide an
alternative strategy for regenerative approaches. HSCs
are known to have multi-lineage hematopoietic differ-
entiation potential and sustain self-renewal activity,
and always are the dream target of induction from pluri-
potent stem cells. Now that more pre-HSC markers are
identified, induction of pre-HSC, which shares abundant
features with HSCs, might be of interests in regenerative
medicine research and prospects for therapy.
More importantly, the single cell RNA-seq data of the
five different stages of HSC precursors and HSCs pro-
vide the possibility of revealing the full spectrum of HSC
development transcriptional machinery. Notably, one of
the 98 pre-HSC signature genes, α-catulin, was reported
to be pivotal for adult HSCs last year [12]. The identifi-
cation of pre-HSC signature genes (including genes
related to transcriptional activity, arterial endothelium,
metabolism, movement, etc.) provide a great avenue to
the understanding of HSC development, differentiation,
and reprogramming.
Questions still remain like whether we could track
the precursors of the pre-HSCs, i.e., Flk-1+ mesodermal
cells. Only about one third of the pre-HSC single cells
are capable of repopulation, does this HSC heterogen-
eity owe to different cell-cycle status or more specified
development stages? Besides the HSC intrinsic regula-
tion, does the embryonic microenvironment play a role
in pre-HSC development? The most important issue
that needs to be addressed in the next step is in vivo
tracking of pre-HSCs in both directions (earlier embryonic
stage and adult aged stage), particularly the role of
embryonic pre-HSCs and HSCs in adult hematopoiesis.
To generate functional HSCs from pluripotent stem
cells for the need of regenerative medicine, we ought to
know much more if not all components of the molecular
network that governs HSC identity.
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